News
Apple Inc. Deserves More Respect
Respected technology reporter Mark Gurman recently published an article in Bloomberg, in which he goes over the key new features to expect in Apple's (NASDAQ: AAPL) upcoming iPhone with OLED....
Apple Inc. Deserves More Respect
Respected technology reporter Mark Gurman recently published an article in Bloomberg, in which he goes over the key new features to expect in Apple's (NASDAQ: AAPL) upcoming iPhone with OLED....
Apple Inc. Deserves More Respect
Respected technology reporter Mark Gurman recently published an article in Bloomberg, in which he goes over the key new features to expect in Apple's (NASDAQ: AAPL) upcoming iPhone with OLED....
2 Marijuana Stocks That Have Imploded Since August Began
In many ways, the legal marijuana industry could be described as the greatest thing since sliced bread for investors. Over the trailing one-year period, the average marijuana stock has increased....
Spirit Airlines Pilot Strike Vote: Less Than Meets the Eye
Earlier this week, pilots at Spirit Airlines (NASDAQ: SAVE) began voting to authorize the union leadership to call a strike if negotiations with the airline break down.To the casual observer, it....
3 Things FireEye Management Wants You to Know
The cybersecurity software company, FireEye (NASDAQ: FEYE), released its second quarter earnings earlier this month. Kevin Mandia, FireEye's CEO, has had 15 months on the job now and can't play....
This May Be The Only Way For Blue Apron to Survive
Blue Apron's (NYSE: APRN) latest earnings report had more red flags than a rough day at the beach.After going through one of the worst IPO's in recent memory, the meal-kit service just gave....
This May Be The Only Way For Blue Apron to Survive
Blue Apron's (NYSE: APRN) latest earnings report had more red flags than a rough day at the beach.After going through one of the worst IPO's in recent memory, the meal-kit service just gave....
This May Be The Only Way For Blue Apron to Survive
Blue Apron's (NYSE: APRN) latest earnings report had more red flags than a rough day at the beach.After going through one of the worst IPO's in recent memory, the meal-kit service just gave....
3 Great Income Stocks that Could Double their Dividends
When searching for income stocks, investors should always study their payout ratios -- the percentage of a company's earnings or free cash flow (FCF) that it spends on dividends. If those ratios....
3 Great Income Stocks that Could Double their Dividends
When searching for income stocks, investors should always study their payout ratios -- the percentage of a company's earnings or free cash flow (FCF) that it spends on dividends. If those ratios....
3 Great Income Stocks that Could Double their Dividends
When searching for income stocks, investors should always study their payout ratios -- the percentage of a company's earnings or free cash flow (FCF) that it spends on dividends. If those ratios....
3 Great Income Stocks that Could Double their Dividends
When searching for income stocks, investors should always study their payout ratios -- the percentage of a company's earnings or free cash flow (FCF) that it spends on dividends. If those ratios....
Like Dividends? This Stock Just Increased Its Payout for the 50th Year in a Row
Federal Realty Investment Trust (NYSE: FRT) is one of the oldest real estate investment trusts, or REITs, and invests in shopping center properties located in seven major U.S. markets. Not only....
3 Reasons AbbVie Is a Better Dividend Stock Than Gilead Sciences
Gilead Sciences (NASDAQ: GILD) claims one of the top-selling drugs in the world with Harvoni. But AbbVie (NYSE: ABBV) markets the best-selling drug in the world -- Humira. Gilead Sciences is one....
How Johnson & Johnson Makes Most of Its Money
As you might expect, Johnson & Johnson (NYSE: JNJ) makes a lot of money. Last year, the healthcare giant generated revenue totaling nearly $72 billion. Over the past decade, J&J raked in....
How Johnson & Johnson Makes Most of Its Money
As you might expect, Johnson & Johnson (NYSE: JNJ) makes a lot of money. Last year, the healthcare giant generated revenue totaling nearly $72 billion. Over the past decade, J&J raked in....
3 Reasons AbbVie Is a Better Dividend Stock Than Gilead Sciences
Gilead Sciences (NASDAQ: GILD) claims one of the top-selling drugs in the world with Harvoni. But AbbVie (NYSE: ABBV) markets the best-selling drug in the world -- Humira. Gilead Sciences is one....
3 Reasons AbbVie Is a Better Dividend Stock Than Gilead Sciences
Gilead Sciences (NASDAQ: GILD) claims one of the top-selling drugs in the world with Harvoni. But AbbVie (NYSE: ABBV) markets the best-selling drug in the world -- Humira. Gilead Sciences is one....
3 Cheap Stocks You Can Buy Right Now
With the market hitting record highs, it's getting more difficult to find attractively priced stocks to invest in. However, thanks to industry-specific weakness, there are still some long-term....
Can Cameco Corp's 4.1% Dividend Yield Survive?
About three months ago I argued that the world's leading uranium producer would be better off suspending its dividend than maintaining it. While Cameco Corp (NYSE: CCJ) shareholders certainly....
Can Cameco Corp's 4.1% Dividend Yield Survive?
About three months ago I argued that the world's leading uranium producer would be better off suspending its dividend than maintaining it. While Cameco Corp (NYSE: CCJ) shareholders certainly....
Losing Sleep Over Your Portfolio? Consider This Stock
Some investors prefer stability. The more volatility in their portfolios, the less they sleep at night. Sound like you? If so, I've got good news: One of the world's best businesses is still....
Losing Sleep Over Your Portfolio? Consider This Stock
Some investors prefer stability. The more volatility in their portfolios, the less they sleep at night. Sound like you? If so, I've got good news: One of the world's best businesses is still....
Losing Sleep Over Your Portfolio? Consider This Stock
Some investors prefer stability. The more volatility in their portfolios, the less they sleep at night. Sound like you? If so, I've got good news: One of the world's best businesses is still....